National Cancer Institute - Articles and news items


FDA expands approved use of Bayer’s liver cancer treatment

Industry news / 2 May 2017 / Niamh Marriott, Junior Editor

The FDA has expanded the approved use of Bayer’s Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma…

Large study shows older breast cancer patients have worse outcomes

Industry news / 13 October 2016 / Niamh Louise Marriott, Digital Content Producer

Results showed that mortality was higher in patients over 70 who were either not tested with Oncotype DX or had a recurrence score result greater than 18…

dna immunotherapy

Lion Biotechnologies announces publication of data from clinical study of metastatic cervical cancer patients treated with HPV-TIL

Industry news, Uncategorized / 8 April 2015 / Victoria White

Lion Biotechnologies has announced that data from a study of metastatic cervical cancer patients treated with treated with HPV-TIL has been published…

Advanced Cell Diagnostics, Inc

Advanced Cell Diagnostics awarded $1.4 million NCI Grant to develop ultrasensitive diagnostic test for B-cell lymphoma

Industry news / 10 October 2014 / Advanced Cell Diagnostics, Inc

Advanced Cell Diagnostics, Inc. has been awarded a two-year, $1.4 million grant from National Cancer Institute…


Amgen joins The National Cancer Institute and Research Partners to help accelerate development of personalized treatment approaches for squamous cell lung cancer

Industry news / 17 June 2014 / Amgen

Amgen announced that it will collaborate with the National Cancer Institute (NCI), part of the National Institutes of Health, and other public and private sector partners on the Lung Master Protocol (Lung-MAP)…

Cancer Biology

Major study reveals new ways to classify cancer

Industry news, News / 27 September 2013 / Cancer Research UK

A US-led initiative to map the molecular similarities and differences of thousands of tumours has revealed new ways to classify cancer…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...